US BANCORP \DE\ - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 52 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,0000.0%2,0000.0%0.00%
Q2 2022$1,0000.0%2,0000.0%0.00%
Q1 2022$1,000
-80.0%
2,0000.0%0.00%
Q4 2021$5,000
-44.4%
2,0000.0%0.00%
Q3 2021$9,0000.0%2,0000.0%0.00%
Q2 2021$9,000
-40.0%
2,0000.0%0.00%
Q1 2021$15,0000.0%2,0000.0%0.00%
Q4 2020$15,000
-16.7%
2,0000.0%0.00%
Q3 2020$18,000
+200.0%
2,000
+166.7%
0.00%
Q2 2020$6,000
+50.0%
7500.0%0.00%
Q1 2020$4,000
-20.0%
7500.0%0.00%
Q4 2019$5,0007500.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Orbimed Advisors 8,466,783$5,758,0000.09%
HARBOR CAPITAL ADVISORS, INC. 226,731$154,0000.07%
Sio Capital Management, LLC 182,630$124,0000.04%
Virtu Financial LLC 71,475$49,0000.00%
Independence Bank of Kentucky 10,200$7,0000.00%
SANDERS MORRIS HARRIS LLC 15,000$10,0000.00%
Endurance Wealth Management, Inc. 1,500$12,0000.00%
Baker Brothers Advisors 451,478$307,0000.00%
Texas Yale Capital Corp. 20,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 79,900$54,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders